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One hundred seven patients were retrospectively studied from 1992 to 2002 with diabetic neuropathy that underwent peripheral
nerve biopsy. Nerve biopsy revealed the underlying histopathology, including cell and humoral-mediated immunological lesions
in the majority of patients. When combined with clinical and laboratory studies, nerve biopsy has the potential to assist in the
selection of patients who may beneﬁt from immunomodulatory therapy.
1.Introduction
There are few modern series of diabetic neuropathy con-
ﬁrmed by nerve tissue obtained at biopsy or postmortem
examination available to allow clinicopathological corre-
lation of the diﬀerent neuropathic syndromes. In 1996,
Younger et al. [1] reported clinicopathological and immuno-
histochemical ﬁndings in 20 patients with heterogeneous
forms of diabetic neuropathy. The present report continues
that series to a total of 107 patients who underwent detailed
clinicopathological assessment.
2. Methods
One hundred seven consecutive patients with diabetes mel-
litus and peripheral neuropathy comprising distal symmet-
rical polyneuropathy (DSPN), proximal diabetic neuropathy
(PDN) hereafter referred to as diabetic lumbosacral radicu-
loplexus neuropathy (DLRPN) [2, 3], and mononeuritis
multiplex (MNM) at the New York Presbyterian Hospital
and New York University Langone Medical Center were
identiﬁed from 1992 to 2002. Causes of neuropathy other
than diabetes mellitus were carefully excluded by appro-
priate investigations. Peripheral neuropathy was established
by standard nerve conduction studies (NCSs) and needle
electromyography (EMG).
Patients with DSPN presented with distal leg sensory
and later motor involvement manifested variably by pain,
paresthesia, limb weakness, gait disturbance, imbalance, and
hyporeﬂexiainthelegs.PatientswithDLRPNpresentedwith
pelvi-femoral pain followed by weakness beginning focally
and unilaterally, aﬀecting the leg and thigh, progressing to
involve the lower leg with spread to the contralateral limb,
combined with sensory loss and concomitant weight loss
ofteninexcessof10pounds.MNMpresentedwithastepwise
pattern of motor and sensory loss in the distribution of
individual peripheral nerves.
Patients were referred for peripheral nerve biopsy after
diagnosis of symptomatic peripheral neuropathy to ascertain
the histopathological basis of neuropathy, not based on
speciﬁc clinical or electrophysiological features and per-
formed along the sural nerve above the ankle according to
standard technique [1, 4] after obtaining informed consent.
All biopsy specimens were analyzed by the Department of
Pathology, Columbia University. The sural nerve was chosen
for biopsy because it is the most widely studied nerve
histopathologically. In all but one patient with MNM, the
sural nerve was involved clinically and electrophysiologically.
The status of control of diabetes mellitus at the time of nerve
biopsy was comparable for all patients.
The neuropathology was classiﬁed as primarily axonopa-
thy and myelinopathy after analysis of semithin epoxy2 Neurology Research International
Table 1: Clinical Characteristics of 107 Patients and Diabetic
Neuropathy.
Study Cohort Number Percentages
Women 36 34
Men 71 66
Mean Age 64.7 years
(Range 31–95 years)
Clinical Neuropathic Syndrome
MNM 1 1
DLRPN 35 33
DSPN 71 66
Histological Severity of Neuropathy
Normal 1 1
Mild 17 16
Moderate 54 50
Severe 35 33
Teased Fiber/Semithin Section Analysis
Normal 1 1
Axonopathy 45 65
Myelinopathy 23 35
Cellular Response
Perivasculitis 26 23
Microvasculitis 3 3
Necrotizing arteritis 3 3
Complement Immunoﬂuorescence
C3 deposition 70 67
C5b-9 65 62
Other Findings
Onion bulb formation 10 9
Epineurial vascular thrombosis 5 5
sections and teased nerve ﬁber preparations. The severity
was categorized as mild, moderate, or severe based upon
the degree of myelinated ﬁber degeneration and loss in
transverse paraﬃn and epoxy sections. Mononuclear inﬂam-
matory cell inﬁltration in or around epineurial vessel walls,
respectively, deﬁned micovasculitis (MV) and perivasculitis
(PV) [1]. Necrotizing arteritis (NA) was diagnosed by active
or healed lesions in arteriae nervorum [5]. The frequency of
MV, PV, and NA was not subcategorized according to the
clinical presentation of neuropathy.
3. Results
The clinical and neuropathological ﬁndings are summarized
inTable1.Twopatientshadjuvenile-onsetdiabetesmellitus,
and the remainder had types 1 and 2 in equal ratio. One
patient had MNM, and the remainder had DSPN and
DLRPN in a 2:1 ratio. Five patients (4%) had minor wound
infection at the incision site that responded to antibiotics
and 5 (4%) had short-lasting postoperative causalgia. One
patient with DSPN had normal nerve pathology.
Theseverityofneuropathywasmildin17%,moderatein
50%, and severe in 33%. Two-thirds of nerves were deemed
Figure 1: Biopsy of sural nerve in cross section in a patient
with diabetic lumbosacral radiculoplexus neuropathy (DLRPN)
demonstrates focal intense mononuclear inﬂammatory cells that
surround and invade the wall of a small epineurial blood vessel on
the right side of the photomicrograph indicative of microvasculitis
(MV) (Cryosection, Immunoperoxidase, 400x).
Figure 2: Biopsy of sural nerve in longitudinal section demon-
strates features of necrotizing arteritis (NA) in a patient with dia-
betic lumbosacral radiculoplexus neuropathy (DLRPN). Numerous
inﬂammatory cells surround a small epineurial artery. The lumen
contains reactive connective tissue with recanalization, thrombus
formation, and vessel wall necrosis. An adjacent nerve fascicle has
a marked loss of myelinated ﬁbers (Cryosection, H&E, 200x).
primary axonopathy, and one-third primary myelinopathy.
Altogether, 3% and 23% of nerves, respectively, revealed MV
(Figure 1) and PV. Immunoﬂuorescence showed C3 and
C5b-9 membrane attack complex deposits in the walls of
endoneurial microvessels in two-thirds of nerves. Necrotiz-
ing arteritis (Figure 2), detected in nerve biopsy tissue of
two patients with DSPN and one DLRPN, was absent in
postmortem tissue of the latter case in which femoral, sciatic
nerve, and lumbar plexus [6] showed PV of the epineurium,
perineurium, and endoneurium.
4. Discussion
The frequency of MV (3%) and PV (23%) was reduced com-
pared to 60% and 40%, respectively, when immunoperoxi-
dase immunoﬂourescent staining was employed [1]. Necro-
tizing arteritis was not veriﬁed in the postmortem studied
case. The 3% frequency of MV in our cohort comparedNeurology Research International 3
favorably with 6% reported in DLRPN [2]. Mononuclear
cell inﬁltration was ﬁrst noted in the peripheral nerves of
patients with diabetes mellitus obtained at postmortem and
in amputated limbs [7]. Later, PV [2, 8], MV [2, 9], and NA
[2,10]w er enot edinsural[2,8],superﬁcialperonealsensory
[2, 9] , and femoral intermedius nerve biopsies [9, 10]. The
inﬁltrating mononuclear inﬂammatory cells proved to be
activated CD8+ T cells expressing pathogenic cytokines and
major histocompatibility class II antigen [1], in association
with activated complement. It was not possible to correlate
the frequency and severity of peripheral nerve inﬂammation
with the clinical forms of diabetic neuropathy in the present
cohort since the nerves demonstrating MV and NA were
very few in number, and those showing PV were not further
stratiﬁed into subgroups of severity. Further, the present
study did not ultrastructurally examine diabetic endoneurial
microvessels that have previously shown reduplication of
basement membranes and pericyte degeneration, which can
lead to alterations in the size or the vessel lumen, thickening
of vessel walls, alterations in the blood-nerve barrier, and
endoneurial microenvironment [11].
Axonopathy was the predominant pathology overall in
the present cohort, however a third of nerves demonstrated
demyelination. The latter has historically been attributed
to axonal degeneration as the primary ischemic event.
Segmental demyelination and remyelination was observed
i n2 3 %o fs u r a ln e r v eb i o p s i e sd u et op r i m a r ya x o n a l
degeneration, and in 12/33 sural nerves in DLRPN [2], with
vascular inﬂammatory cell collections. Anecdotal reports of
patients with chronic inﬂammatory demyelinating polyneu-
ropathy (CIDP) and diabetes mellitus [12]s u p p o r tp r i m a r y
autoimmune demyelinating nerve disease, however we were
unable to retrospectively deﬁne cases of CIDP according to
strict criteria available during the study period [13].
Theﬁndingofnecrotizingarteritisandmicrovasculitisin
the peripheral nerve biopsies of several patients with hetero-
geneous forms of diabetic neuropathy lends further support
to ischemic axonopathy without invoking a concomitant
systemic vasculitic process. Patchy ﬁber loss of upper sciatic
nerve with severe length-dependent distal ﬁber loss and
axonopathy [12] was noted in postmortem tissue of two
diabetics with distal symmetrical sensory polyneuropathy
and reminiscent of necrotizing angiopathic neuropathy
(NAN) [14]. Notwithstanding, it remains enigmatic that
neither systemic nor widespread peripheral nerve vasculitis
wasdetectedinpostmortemtissuefromthepatientswithNA
in sural nerve biopsy, or in the postulated cases of diabetic
NAN [12]; more likely, MV and severe PV contribute more
to epineurial ischemia than does NA.
Although this study did not examine treatment choices
made for individual patients or subgroups of the cohort
based upon nerve biopsy results, the present ﬁndings of sural
nerve inﬂammation and demyelination may be a clue to an
underlying autoimmune etiopathogenesis in some aﬀected
patients. Future studies should address the elucidation of
prospective clinical and laboratory criteria to select patients
for open peripheral nerve biopsy in view of the availability
of epidermal nerve ﬁber (ENF) studies by punch skin biops
[15] .T h el a t t e ri sl e s si n v a s i v ea n di n s t e a dm e a s u r e sE N F
density and histology but does not sample large myelinated
nerve ﬁber bundles or epineurial blood vessels which may be
clue to systemic or nonsystemic peripheral nerve vasculitis
[16].
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